Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc S Ernstoff

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Therapy (London, England : 2004)|August 27, 2011
Therapeutic vaccines in renal cell carcinomaThomas Schwaab, Marc S Ernstoff
Cancer|March 26, 2003
Modulation of antitumor immune responses by hematopoietic cytokinesEdmund K Waller, Marc S Ernstoff
British Journal of Clinical Pharmacology|May 28, 2008
The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?Barrett W Newsome, Marc S Ernstoff
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Mechanism of resistance to immune checkpoint inhibitorsManu R Pandey, Marc S Ernstoff
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Immunotherapy for the treatment of glioblastomaAlissa A Thomas, Marc S Ernstoff, Camilo E Fadul
Experimental Hematology & Oncology|March 19, 2013
Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivoStephen H Wrzesinski, Jan L Fisher, Marc S Ernstoff
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity ManagementMichael J Overman, Marc S Ernstoff, Michael A Morse
Medicine|November 7, 2019
Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case reportYara Abdou, Ankita Kapoor, Lamya Hamad, et al.
Journal of Immunological Sciences|April 12, 2019
A Review of Exosomes and their Role in The Tumor Microenvironment and Host-Tumor "Macroenvironment"Kaity H Tung, Marc S Ernstoff, Cheryl Allen, et al.
Clinical Genitourinary Cancer|June 8, 2007
Radiation therapy and sorafenib: clinical data and rationale for the combination in metastatic renal cell carcinomaMohit Kasibhatla, Peter Steinberg, Jeffrey Meyer, et al.
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Therapy (London, England : 2004)|August 27, 2011
Therapeutic vaccines in renal cell carcinomaThomas Schwaab, Marc S Ernstoff
Cancer|March 26, 2003
Modulation of antitumor immune responses by hematopoietic cytokinesEdmund K Waller, Marc S Ernstoff
British Journal of Clinical Pharmacology|May 28, 2008
The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?Barrett W Newsome, Marc S Ernstoff
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Mechanism of resistance to immune checkpoint inhibitorsManu R Pandey, Marc S Ernstoff
Cancer Journal (Sudbury, Mass.)|February 1, 2012
Immunotherapy for the treatment of glioblastomaAlissa A Thomas, Marc S Ernstoff, Camilo E Fadul
Experimental Hematology & Oncology|March 19, 2013
Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivoStephen H Wrzesinski, Jan L Fisher, Marc S Ernstoff
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity ManagementMichael J Overman, Marc S Ernstoff, Michael A Morse
Medicine|November 7, 2019
Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case reportYara Abdou, Ankita Kapoor, Lamya Hamad, et al.
Journal of Immunological Sciences|April 12, 2019
A Review of Exosomes and their Role in The Tumor Microenvironment and Host-Tumor "Macroenvironment"Kaity H Tung, Marc S Ernstoff, Cheryl Allen, et al.
Clinical Genitourinary Cancer|June 8, 2007
Radiation therapy and sorafenib: clinical data and rationale for the combination in metastatic renal cell carcinomaMohit Kasibhatla, Peter Steinberg, Jeffrey Meyer, et al.
Pageof 17